ARTICLE | Clinical News
Rifaximin regulatory update
January 4, 2010 8:00 AM UTC
FDA's Gastrointestinal Drugs Advisory Committee will meet on Feb. 23 to discuss an NDA from Salix for rifaximin 550 mg tablets for the maintenance of remission of hepatic encephalopathy. In November, ...